A PYMNTS Company

India: $3.2B merger creates pharmaceutical behemoth

By  |  April 7, 2014

India’s largest pharmaceutical companies have inked a $3.2 billion deal to merge, reports said Monday.

Top drug maker Sun Pharmaceuticals Industries will acquire its rival Ranbaxy Laboratories in an all-stock deal, say reports.

Japan-based Daiichi Sankyo currently controls Ranbaxy with a 68 percent stake; reports say following the merger Daiichi Sankyo will emerge as Sun Pharma’s second-largest shareholder.

The deal is set to create a global pharmaceutical giant operating in 65 countries, reports say.

Full Content: Live Mint

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.